HIV and AIDS Archives

PrEP not reaching those who could potentially benefit from it the most

March 8, 2018

A new CDC study suggests that only a small percentage of Americans who could potentially benefit from pre-exposure prophylaxis (PrEP), a daily pill for HIV prevention, have been prescribed it. In the first detailed analysis by race and by risk group, CDC researchers found while two-thirds of those who could potentially benefit from PrEP are… [Read More]